Results 61 to 70 of about 20,230 (210)

Computed Tomography Findings in Pathology-Confirmed Rhino-Orbital Mucormycosis During the COVID-19 Era: A Retrospective Cross-Sectional Study. [PDF]

open access: yesHealth Sci Rep
ABSTRACT Background and Aims Rhino‐orbital mucormycosis (ROM) emerged as a severe complication during the COVID‐19 era, particularly in immunocompromised patients. Computed tomography (CT) plays a critical role in early detection and assessment of disease extent.
Naraghi M   +3 more
europepmc   +2 more sources

Pulmonary embolism and gastric bleed with disseminated mucormycosis - treading dangerous waters

open access: yesMonaldi Archives for Chest Disease, 2022
Mucormycosis is an opportunistic infection seen in immunocompromised patients or in surgical and trauma settings with Mucorales wound contamination. In immunocompetent people, disseminated mucormycosis is uncommon.
Nishant Kumar Chauhan   +4 more
doaj   +1 more source

Gastrointestinal mucormycosis-an uncommon isolated mucormycosis. [PDF]

open access: yes, 1998
Background: Isolated mucormycosis of the gastrointestinal tract is uncommon, with only two case reports from India. Objectives: To study the clinicopathologic features of gastrointestinal mucormycosis in Indian patients.
Kataria, R.   +6 more
core   +1 more source

Ravulizumab Shows Favorable Survival and Improves Clinical Markers in Children With HSCT‐TMA: Results of a Phase 3 Trial

open access: yesAmerican Journal of Hematology, EarlyView.
Pediatric HSCT‐TMA: Results of a global Phase 3 trial of ravulizumab. ABSTRACT Hematopoietic stem cell transplantation‐associated thrombotic microangiopathy (HSCT‐TMA) is a rare, life‐threatening complication that can lead to multiorgan failure and death.
Franco Locatelli   +15 more
wiley   +1 more source

An insight into the pathophysiology of mucormycosis: Lesson learnt during COVID pandemic

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology
Mucormycosis, a lethal fungal infection caused by Rhizopus oryzae, has gained significant attention due to its association with the COVID-19 pandemic. The causal relationship between COVID-19 and mucormycosis is not yet fully understood.
Sukanti Bhattacharyya   +2 more
doaj   +1 more source

Dual biologic therapy in inflammatory bowel disease, a retrospective cohort study of vedolizumab and anti‐tumor necrosis factor alpha therapy in children

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Despite advances in pediatric inflammatory bowel disease (PIBD) with biologics, remission rates remain at 47%–60% with loss‐of‐response rates at 60%–68%. Evidence for efficacy of dual biologic therapy (DBT) with anti‐tumor necrosis factor alpha therapy (anti‐TNF‐α)‐ vedolizumab (VDZ) for children refractory to anti‐TNF‐α therapy is ...
Jonathan E. M. O'Donnell   +6 more
wiley   +1 more source

MUCORMYCOSIS – A CASE SERIES. [PDF]

open access: yes, 2012
Mucormycosis is a rare opportunistic fungal infection with a rapidly progressive and fulminantcourse with often fatal outcome. A less fulminant variety of this is the Rhino maxillary subtypewhich usually presents with palatal ulceration, facial swelling,
Gopalakrishnan, Shankaranarayanan; Kilpauk Medical College
core  

Invasive Rhinoscleroma Mimicking an Aggressive Sinonasal Neoplasm: A Diagnostic Challenge—A Rare Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
Rhinoscleroma (First Case Reported from Somali). ABSTRACT Rhinoscleroma is a chronic granulomatous infection of the upper respiratory tract caused by Klebsiella rhinoscleromatis. We report, to our knowledge, the first published case from Somalia. A 60‐year‐old woman presented after two years of progressive right proptosis, nasal obstruction, and ...
Mohamed Ali Kahiye   +4 more
wiley   +1 more source

Future Directions in Mucormycosis Research

open access: yes, 2012
Mucormycosis has emerged as an important opportunistic infection, especially in severely immunosuppressed hosts. The evolving epidemiology, immunopathogenesis, molecular virulence studies, early diagnosis, and pitfalls in designing clinical studies of ...
T. J. Walsh   +7 more
core   +3 more sources

COVID-19-Associated Mucormycosis, A New Incident in Recent Time: Is An Emerging Disease in The Near Future Impending?

open access: yesAvicenna Journal of Medicine, 2021
Mucormycosis (also known as black fungus) is caused by fungi of the Zygomycetes class and is the third most common invasive mycosis after candidiasis and aspergillosis. They colonize a large number of patients without invading them.
Suman Kumar Ray, Sukhes Mukherjee
doaj   +1 more source

Home - About - Disclaimer - Privacy